caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1952398901

Ana CafengiuDPM

PRACTICECAFENGIU PODIATRY & SPORTS MEDICINE, LLCSee all providers at this practice →
PodiatryMoorestown, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Ana Cafengiu's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
116256
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
70170
David Bechtel
Family Practice · Moorestown, NJ
2867
VIRTUA - MEMORIAL HOSPITAL BURLINGTON COUNTY, INC.2657
SPECTOR, JENNIFER1734
GOLDSTEIN, CHARLES1220
Bakotic Pathology Associates, Llc
Clinical Laboratory · Alpharetta, GA
1129
Ralph Russo
Cardiology · Moorestown, NJ
1114
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
764
Unique beneficiaries
—
Total services
1,718
Distinct HCPCS
10
Medicare payment
$80K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 902 Podiatry providers in NJ — above median (cohort median 1,700).
PRESCRIBING · PART D · 2024
Total Rx claims
40
Beneficiaries
—
Total drug cost
$201
Distinct drugs
2
Brand share
0.0%
Top prescribed drugs
Cephalexin22 claims
Meloxicam18 claims
QUALITY · MIPS · 2024
Final MIPS score
45.0
Quality
90.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-3.60%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.